Skip to main content
AXTA
NYSE Industrial Applications And Services

Axalta Exceeds Q1 Guidance with Strong Cash Flow; Provides Q2 and Full-Year 2026 Outlook

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Positive
Importance info
7
Price
$28.21
Mkt Cap
$6.019B
52W Low
$24.937
52W High
$35.72
52W Position info
13% above low
Off High info
21% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

AXTA is trading near its 52-week low of $24.937 (13% above the low).

Summary

Axalta Coating Systems announced first-quarter 2026 financial results, exceeding its guidance for key metrics and reporting record cash flow, while also providing its outlook for the second quarter and full year.


Key Events · Earnings and Guidance · AXTA

  • Exceeded Q1 Guidance

    Axalta surpassed its guidance for first-quarter net sales, Adjusted EBITDA ($259 million), and Adjusted Diluted EPS ($0.56).

  • Record Cash Flow Generation

    The company reported record first-quarter cash provided by operating activities of $68 million and record free cash flow of $21 million, both significantly up year-over-year.

  • Provided Q2 and Full-Year 2026 Outlook

    Axalta projects Q2 2026 Adjusted Diluted EPS of approximately $0.65 and full-year 2026 Adjusted Diluted EPS between $2.55 and $2.70, with full-year free cash flow expected to be over $500 million.

  • Progress on AkzoNobel Merger

    Management confirmed that workstreams associated with the proposed merger of equals with AkzoNobel are progressing as planned and are on track with the stated timeline.


Analysis · AXTA · Industrial Applications And Services

Axalta Coating Systems reported first-quarter results that surpassed its own guidance for net sales, Adjusted EBITDA, and Adjusted Diluted EPS, demonstrating operational strength despite a dynamic macroeconomic environment. The company also achieved record first-quarter cash flow from operations and free cash flow, indicating improved liquidity and financial health. While some year-over-year metrics saw declines, the beat on expectations and robust cash generation are positive signals. The updated guidance for Q2 and full-year 2026 provides investors with a clearer forward-looking picture, and the company confirmed it is on track with the proposed merger of equals with AkzoNobel, a significant strategic event previously disclosed.

At the time of this filing, AXTA was trading at $28.21 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $6B. The 52-week trading range was $24.94 to $35.72. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AXTA - Latest Insights

AXTA
Jul 29, 2026, 12:04 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $35.32
Real-time Price: $34.97 info
Change: -$0.345 (-0.98%) info
Market Cap: $7.484B info
AXTA
Jul 29, 2026, 7:04 AM EDT
Filing Type: 425
Importance Score:
8
Price at Filing: $34.69
Real-time Price: $34.97 info
Change: +$0.280 (+0.81%) info
Market Cap: $7.484B info
AXTA
Jul 29, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $34.69
Real-time Price: $34.97 info
Change: +$0.280 (+0.81%) info
Market Cap: $7.484B info
AXTA
Jul 28, 2026, 5:20 PM EDT
Filing Type: 425
Importance Score:
7
Price at Filing: $34.73
Real-time Price: $34.97 info
Change: +$0.240 (+0.69%) info
Market Cap: $7.484B info
AXTA
Jul 28, 2026, 5:19 PM EDT
Filing Type: 425
Importance Score:
7
Price at Filing: $34.73
Real-time Price: $34.97 info
Change: +$0.240 (+0.69%) info
Market Cap: $7.484B info